Compare MGY & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MGY | LGND |
|---|---|---|
| Founded | 2017 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 3.9B |
| IPO Year | 2017 | 1992 |
| Metric | MGY | LGND |
|---|---|---|
| Price | $23.74 | $205.70 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 6 |
| Target Price | $26.00 | ★ $243.50 |
| AVG Volume (30 Days) | ★ 2.1M | 210.9K |
| Earning Date | 02-05-2026 | 02-26-2026 |
| Dividend Yield | ★ 2.53% | N/A |
| EPS Growth | N/A | ★ 0.76 |
| EPS | 1.80 | ★ 2.49 |
| Revenue | ★ $1,320,826,000.00 | $251,233,000.00 |
| Revenue This Year | $1.00 | $47.71 |
| Revenue Next Year | $1.20 | $9.77 |
| P/E Ratio | ★ $13.19 | $80.11 |
| Revenue Growth | 0.68 | ★ 64.83 |
| 52 Week Low | $19.09 | $93.58 |
| 52 Week High | $26.47 | $212.49 |
| Indicator | MGY | LGND |
|---|---|---|
| Relative Strength Index (RSI) | 65.25 | 59.66 |
| Support Level | $22.18 | $188.13 |
| Resistance Level | $23.33 | $199.35 |
| Average True Range (ATR) | 0.68 | 9.00 |
| MACD | 0.21 | 0.55 |
| Stochastic Oscillator | 95.40 | 87.20 |
Magnolia Oil & Gas Corp is an independent oil and natural gas company engaged in the acquisition, development, exploration, and production of oil, natural gas, and natural gas liquid (NGL) reserves. The company's oil and natural gas properties are located in Karnes County and the Giddings area in South Texas, where the Company targets the Eagle Ford Shale and Austin Chalk formations. Its objective is to generate stock market value over the long term through consistent organic production growth, high full-cycle operating margins, and an efficient capital program with short economic paybacks. The company's operating segment is acquisition, development, exploration, and production of oil and natural gas properties located in the United States.
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.